Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Stomatitis 2Nasopharyngeal Carcinoma 2Nasopharyngeal Neoplasms 1

Interventions

Cisplatin 6Radiotherapy, Intensity-Modulated 4Saline Solution 3Injections 3golotimod 2avasopasem manganese 2Water 2Vitamin B 12 2Standard of Care 2RRx-001 2Practice Guidelines as Topic 2Gentamicins 2Fibroblast Growth Factor 7 2FGF20 protein, human 2Drug Therapy 2samital 1regramostim 1peppermint oil 1meclocycline 1hydrated silica gel-based toothpaste 1holy basil leaf extract 1cobiprostone 1clazakizumab 1calcium phosphate 1brilacidin 1anise oil 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Stomatitis × Gentamicins × Clear all
NCT03778008 2018-12-27

Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis

Second Affiliated Hospital of Nanchang University

Phase 2 Unknown
90 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Stomatitis

NCT02735317 2016-04-12

Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT

Sun Yat-sen University

Phase 2 Unknown
90 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡